Insider buying
~$129K100K sh @ $1.29
4 days before an 8-KTraded Sep 9, 2025 · filed 3 days later
A Standard Biotools director paid $129K out of pocket for Standard Biotools shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 12, 2025
3 tracked managers disclosed the same change for Q3 2025. From a 13F filed Nov 12, 2025 covering holdings at Sep 30, 2025 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Reduced
Compared with the manager's Q2 2025 13F
3,155,055
3,021,728
−4.2%
Share count drives classification; reported value also moves with price
0.02%
Within the filing's reported positions, not the manager's total assets
3
For Q3 2025
Insider buying
4 days before an 8-KTraded Sep 9, 2025 · filed 3 days later
A Standard Biotools director paid $129K out of pocket for Standard Biotools shares.
Insider buying
10 days before an 8-KTraded Sep 3, 2025 · filed 2 days later
A Standard Biotools director paid $316K out of pocket for Standard Biotools shares.
Insider buying
9 days before an 8-KTraded Sep 4, 2025 · filed 1 day later
A Standard Biotools director paid $319K out of pocket for Standard Biotools shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.